<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.thecerbatgem.com/2019/11/21/inspire-medical-systems-nyseinsp-insider-randy-ban-sells-6390-shares.html"/>
    <meta property="og:site_name" content="The Cerbat Gem"/>
    <meta property="article:published_time" content="2019-11-21T11:46:42+00:00"/>
    <meta property="og:title" content="Inspire Medical Systems (NYSE:INSP) Insider Randy Ban Sells 6,390 Shares"/>
    <meta property="og:description" content="Inspire Medical Systems (NYSE:INSP) insider Randy Ban sold 6,390 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $65.79, for a total transaction of $420,398.10. Randy Ban also recently made the following trade(s): On Tuesday, October 29th, Randy Ban sold 19,300 shares of Inspire […]"/>
  </head>
  <body>
    <article>
      <h1>Inspire Medical Systems (NYSE:INSP) Insider Randy Ban Sells 6,390 Shares</h1>
      <address><time datetime="2019-11-21T11:46:42+00:00">21 Nov 2019, 11:46</time> by <a rel="author" href="https://www.thecerbatgem.com/author/scott" target="_blank">Scott Moore</a></address>
      <figure>
        <img src="https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?w=250&amp;zc=1&amp;src=https://www.marketbeat.com/logos/inspire-medical-systems-logo.jpg"/>
      </figure>
      <p>Inspire Medical Systems (NYSE:INSP) insider Randy Ban sold 6,390 shares of the stock in a transaction dated Monday, November 18th. The stock was sold at an average price of $65.79, for a total transaction of $420,398.10.</p>
      <p>Randy Ban also recently made the following trade(s):</p>
      <ul>
        <li>On Tuesday, October 29th, Randy Ban sold 19,300 shares of Inspire Medical Systems stock. The shares were sold at an average price of $59.16, for a total transaction of $1,141,788.00.</li>
        <li>On Thursday, September 12th, Randy Ban sold 10,000 shares of Inspire Medical Systems stock. The shares were sold at an average price of $61.62, for a total transaction of $616,200.00.</li>
      </ul>
      <p><a href="https://www.marketbeat.com/stocks/NYSE/INSP/insider-trades/">NYSE INSP</a> traded up $0.87 during trading hours on Thursday, reaching $66.19. The company’s stock had a trading volume of 811 shares, compared to its average volume of 300,867. The firm has a fifty day simple moving average of $58.87 and a 200-day simple moving average of $60.90. The stock has a market cap of $1.57 billion, a P/E ratio of -43.99 and a beta of 1.22. Inspire Medical Systems has a 52 week low of $35.43 and a 52 week high of $71.71. The company has a debt-to-equity ratio of 0.17, a current ratio of 13.42 and a quick ratio of 13.05.</p>
      <p>Inspire Medical Systems (NYSE:INSP) last issued its quarterly earnings data on Tuesday, November 5th. The company reported ($0.34) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.09. The business had revenue of $20.86 million during the quarter, compared to analyst estimates of $19.15 million. Inspire Medical Systems had a negative net margin of 40.36% and a negative return on equity of 18.67%. The firm’s quarterly revenue was up 59.8% on a year-over-year basis. During the same quarter last year, the business earned ($0.22) EPS. On average, research analysts expect that Inspire Medical Systems will post -1.46 earnings per share for the current year.</p>
      <p>A number of brokerages recently issued reports on INSP. <a href="https://www.americanconsumernews.net/scripts/click.aspx?ValuEngine=1&amp;Symbol=INSP">ValuEngine</a> lowered shares of Inspire Medical Systems from a “hold” rating to a “sell” rating in a report on Thursday, October 31st. Berenberg Bank upgraded shares of Inspire Medical Systems from a “sell” rating to a “hold” rating and raised their price objective for the company from $46.00 to $51.00 in a report on Wednesday, November 6th. Dougherty &amp; Co set a $78.00 price objective on shares of Inspire Medical Systems and gave the company a “buy” rating in a report on Friday, September 27th. Finally, <a href="https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1">Zacks Investment Research</a> upgraded shares of Inspire Medical Systems from a “hold” rating to a “strong-buy” rating and set a $69.00 price objective for the company in a report on Saturday, November 9th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has given a buy rating and one has given a strong buy rating to the company. Inspire Medical Systems currently has an average rating of “Hold” and a consensus price target of $68.25.</p>
      <p>A number of large investors have recently added to or reduced their stakes in the business. Morgan Stanley increased its position in Inspire Medical Systems by 3.6% during the 2nd quarter. Morgan Stanley now owns 1,441,080 shares of the company’s stock valued at $87,401,000 after purchasing an additional 50,166 shares during the period. BlackRock Inc. increased its position in Inspire Medical Systems by 43.5% during the 2nd quarter. BlackRock Inc. now owns 1,406,301 shares of the company’s stock valued at $85,293,000 after purchasing an additional 426,425 shares during the period. William Blair Investment Management LLC increased its position in Inspire Medical Systems by 5.9% during the 2nd quarter. William Blair Investment Management LLC now owns 1,160,880 shares of the company’s stock valued at $70,407,000 after purchasing an additional 64,785 shares during the period. Invesco Ltd. increased its position in Inspire Medical Systems by 279.8% during the 2nd quarter. Invesco Ltd. now owns 965,710 shares of the company’s stock valued at $58,570,000 after purchasing an additional 711,435 shares during the period. Finally, Vanguard Group Inc. increased its position in Inspire Medical Systems by 12.8% during the 2nd quarter. Vanguard Group Inc. now owns 795,694 shares of the company’s stock valued at $48,258,000 after purchasing an additional 90,413 shares during the period. 86.57% of the stock is owned by institutional investors and hedge funds.</p>
      <p>
        <b>Inspire Medical Systems Company Profile</b>
      </p>
      <p>Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.</p>
      <p>Recommended Story: <a href="https://www.marketbeat.com/market-indexes/">Market Indexes</a></p>
      <figure>
        <img src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=INSP"/>
      </figure>
    </article>
  </body>
</html>